[ {
  "sentence_tokens" : [ "Furthermore", ",", "MEK", "inhibitor", "exposure", "induced", "protein", "levels", "of", "pro", "apoptotic", "BIM", ",", "most", "evidently", "for", "KOPN8", ",", "while", "p53", "levels", "remained", "unaffected", "(", "Supplementary", "Figure", "5", ")", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ],
  "type" : "Negative_regulation",
  "polarity" : false,
  "controller_indices" : [ 2, 3, 4 ],
  "controlled_indices" : [ 7, 8, 9, 10, 11, 12 ],
  "trigger_indices" : [ 5, 6 ],
  "rule_name" : "Positive_regulation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "However", ",", "we", "did", "confirm", "that", "MEK", "inhibitors", "reduced", "p-ERK", "levels", ",", "and", "induced", "apoptosis", "in", "the", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11 ],
  "type" : "Negative_regulation",
  "polarity" : false,
  "controller_indices" : [ 6, 7, 8 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 8, 9 ],
  "rule_name" : "Negative_regulation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Interestingly", ",", "Nakanishi", "et", "al.", "previously", "demonstrated", "that", "MLL-fusion", "proteins", "can", "induce", "ERK", "phosphorylation", "through", "regulating", "EphA7", "receptor", "tyrosine", "kinase", "expression", ",", "but", "this", "was", "not", "accompanied", "by", "increased", "RAF", "or", "MEK", "phosphorylation", "[", "21", "]", "." ],
  "event_indices" : [ 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Positive_regulation",
  "polarity" : true,
  "controller_indices" : [ 8, 9, 10 ],
  "controlled_indices" : [ 12, 13, 14 ],
  "trigger_indices" : [ 11, 12 ],
  "rule_name" : "Positive_regulation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Hence", ",", "although", "MEK", "activation", "in", "presence", "of", "GDC-0973", ",", "MEK162", "or", "Selumetinib", "can", "still", "occur", ",", "the", "transduction", "of", "the", "signal", "by", "MEK", "mediated", "phosphorylation", "of", "ERK", "is", "no", "longer", "possible", ",", "as", "we", "show", "in", "Figure", "4.Recently", ",", "we", "found", "the", "presence", "of", "RAS", "mutations", "in", "MLL", "rearranged", "infant", "ALL", "cells", "correlated", "with", "prednisolone", "resistance", ",", "an", "obstacle", "in", "the", "treatment", "of", "infant", "ALL", "[", "2", ",", "3", "]", "." ],
  "event_indices" : [ 23, 24, 25, 26, 27, 28 ],
  "type" : "Positive_regulation",
  "polarity" : true,
  "controller_indices" : [ 23, 24 ],
  "controlled_indices" : [ 25, 26, 27, 28 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Positive_early_regulation",
  "rule" : null
}, {
  "sentence_tokens" : [ "Additionally", ",", "Salirasib", "and", "Vemurafenib", "did", "not", "substantially", "reduce", "cell", "viability", ",", "even", "at", "high", "concentrations", "(", ">", "10", "mu", "M", ")", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 2, 3 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 8, 9 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Additionally", ",", "Salirasib", "and", "Vemurafenib", "did", "not", "substantially", "reduce", "cell", "viability", ",", "even", "at", "high", "concentrations", "(", ">", "10", "mu", "M", ")", "." ],
  "event_indices" : [ 4, 5, 6, 7, 8, 9, 10, 11 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 4, 5 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 8, 9 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Interestingly", ",", "while", "Trametinib", "by", "itself", "induced", "only", "minor", "cell", "viability", "decrease", "in", "SEM", "cells", "(", "Figure", "6B", ")", ",", "the", "combination", "of", "Trametinib", "and", "prednisolone", "greatly", "enhanced", "the", "efficacy", "of", "prednisolone", ",", "especially", "at", "higher", "concentrations", "(", "Figure", "6A", ")", "." ],
  "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 3, 4 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 6, 7 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Interestingly", ",", "Kampen", "et", "al.", "recently", "proposed", "a", "MEK", "inhibitor", "escape", "mechanism", "in", "MLL", "rearranged", "AML", ",", "which", "was", "mediated", "by", "VEGFR-2", "and", "PI3K", "signaling", ",", "and", "we", "wondered", "whether", "this", "could", "play", "a", "role", "in", "the", "MEK", "inhibitor", "resistance", "of", "our", "wildtype", "patient", "cells", "[", "5", "]", "." ],
  "event_indices" : [ 13, 14, 15, 16, 17, 18, 19, 20, 21, 22 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 21, 22 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 19, 20 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "MEK", "inhibitors", "MEK162", ",", "Selumetinib", "and", "Trametinib", "significantly", "reduce", "viability", "of", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 5, 6 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "MEK", "inhibitors", "MEK162", ",", "Selumetinib", "and", "Trametinib", "significantly", "reduce", "viability", "of", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Additionally", ",", "no", "differences", "in", "p-ERK", "levels", "were", "found", "between", "RAS-wildtype", "and", "RAS-mutant", "samples", "(", "Figure", "3D", ")", ",", "nor", "between", "RAS-wildtype", "cells", "that", "were", "sensitive", "or", "resistant", "to", "MEK", "inhibition.In", "MLL", "rearranged", "AML", ",", "MEK", "inhibitor", "resistance", "can", "occur", "through", "activation", "of", "tyrosine", "kinase", "receptor", "(", "TKR", ")", "signaling", "(", "i.e.", "involving", "VEGFR-2", ")", "[", "5", "]", "." ],
  "event_indices" : [ 29, 30, 31, 32 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 31, 32 ],
  "controlled_indices" : [ 29, 30 ],
  "trigger_indices" : [ 30, 31 ],
  "rule_name" : "Negative_activation_token_1_noun",
  "rule" : null
}, {
  "sentence_tokens" : [ "Moreover", ",", "RAS", "pathway", "inhibition", ",", "including", "MEK", "inhibition", ",", "was", "previously", "shown", "to", "effectively", "inhibit", "RAS-mutant", "MLL", "rearranged", "AML", "in", "vitro", "[", "5", ",", "6", "]", "." ],
  "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 17, 18 ],
  "trigger_indices" : [ 15, 16 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Recently", ",", "Irving", "et", "al.", "already", "showed", "that", "Selumetinib", "effectively", "inhibits", "leukemia", "progression", "in", "an", "in", "vivo", "model", "of", "RAS-mutant", "BCP-ALL", ",", "and", "Burgess", "et", "al.", "found", "Trametinib", "to", "prolong", "the", "survival", "of", "mice", "transplanted", "with", "NRAS", "AML", "cells", "[", "12", ",", "13", "]", "." ],
  "event_indices" : [ 8, 9, 10, 11, 12 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 8, 9 ],
  "controlled_indices" : [ 11, 12 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 16, 17, 18, 19, 20, 21, 22 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 19, 20, 21, 22 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 17, 18 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 13, 14, 15, 16, 17, 18, 19, 20, 21, 22 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 19, 20, 21, 22 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 17, 18 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Interestingly", ",", "while", "Trametinib", "by", "itself", "induced", "only", "minor", "cell", "viability", "decrease", "in", "SEM", "cells", "(", "Figure", "6B", ")", ",", "the", "combination", "of", "Trametinib", "and", "prednisolone", "greatly", "enhanced", "the", "efficacy", "of", "prednisolone", ",", "especially", "at", "higher", "concentrations", "(", "Figure", "6A", ")", "." ],
  "event_indices" : [ 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 23, 24 ],
  "controlled_indices" : [ 31, 32 ],
  "trigger_indices" : [ 27, 28 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Moreover", ",", "Ari", "e", "s", "et", "al.", "found", "Trametinib", "could", "restore", "prednisolone", "sensitivity", "in", "RAS-mutant", "BCP-ALL", "patient", "samples", ",", "whereas", "Rambal", "et", "al.", "showed", "that", "MEK", "activation", "reduces", "dexamethasone", "sensitivity", ",", "and", "the", "MEK", "inhibitor", "PD183452", "enhanced", "dexamethasone", "responses", "in", "ALL", "cells", "in", "a", "BIM", "dependent", "manner", "[", "24", ",", "25", "]", "." ],
  "event_indices" : [ 25, 26, 27, 28, 29 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 25, 26 ],
  "controlled_indices" : [ 28, 29 ],
  "trigger_indices" : [ 27, 28 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Here", "we", "show", "that", "the", "MEK", "inhibitors", "Trametinib", ",", "Selumetinib", "and", "MEK162", "severely", "impair", "primary", "RAS-mutant", "MLL", "rearranged", "infant", "ALL", "cells", "in", "vitro", "." ],
  "event_indices" : [ 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 5, 6, 7 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 13, 14 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Remarkably", ",", "our", "present", "data", "shows", "that", "MEK", "inhibition", "strongly", "enhances", "the", "sensitivity", "of", "both", "RAS-wildtype", "and", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "to", "prednisolone", ",", "also", "further", "exemplifying", "the", "possible", "value", "of", "MEK", "inhibitors", "for", "RAS-mutant", ",", "as", "well", "as", "RAS-wildtype", ",", "MLL", "rearranged", "infant", "ALL", "patients", "." ],
  "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 40, 41 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Remarkably", ",", "our", "present", "data", "shows", "that", "MEK", "inhibition", "strongly", "enhances", "the", "sensitivity", "of", "both", "RAS-wildtype", "and", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "to", "prednisolone", ",", "also", "further", "exemplifying", "the", "possible", "value", "of", "MEK", "inhibitors", "for", "RAS-mutant", ",", "as", "well", "as", "RAS-wildtype", ",", "MLL", "rearranged", "infant", "ALL", "patients", "." ],
  "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 42, 43 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Moreover", ",", "RAS", "pathway", "inhibition", ",", "including", "MEK", "inhibition", ",", "was", "previously", "shown", "to", "effectively", "inhibit", "RAS-mutant", "MLL", "rearranged", "AML", "in", "vitro", "[", "5", ",", "6", "]", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 2, 3 ],
  "controlled_indices" : [ 17, 18 ],
  "trigger_indices" : [ 15, 16 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "As", "shown", "in", "Figure", "6A", ",", "prednisolone", "alone", "decreased", "cell", "viability", "of", "SEM", "cells", "to", "only", "~", "50", "%", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 6, 7 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 8, 9 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Moreover", ",", "RAS", "pathway", "inhibition", ",", "including", "MEK", "inhibition", ",", "was", "previously", "shown", "to", "effectively", "inhibit", "RAS-mutant", "MLL", "rearranged", "AML", "in", "vitro", "[", "5", ",", "6", "]", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 2, 3 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Negative_activation_syntax_noun_Hearst",
  "rule" : null
}, {
  "sentence_tokens" : [ "Activated", "ERK", "can", "phosphorylate", "BIM", ",", "targeting", "it", "for", "proteasomal", "degradation", ",", "and", "thereby", "diminishing", "apoptosis", "induced", "by", "dexamethasone", "[", "26", "]", "." ],
  "event_indices" : [ 15, 16, 17, 18, 19 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 18, 19 ],
  "controlled_indices" : [ 15, 16 ],
  "trigger_indices" : [ 16, 17 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Temsirolimus", "and", "Sorafenib", "potently", "reduced", "cell", "viability", "of", "both", "RAS-mutant", "and", "RAS-wildtype", "cell", "lines", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 2, 3 ],
  "controlled_indices" : [ 5, 6, 7 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Temsirolimus", "and", "Sorafenib", "potently", "reduced", "cell", "viability", "of", "both", "RAS-mutant", "and", "RAS-wildtype", "cell", "lines", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 5, 6, 7 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Interestingly", ",", "while", "Trametinib", "by", "itself", "induced", "only", "minor", "cell", "viability", "decrease", "in", "SEM", "cells", "(", "Figure", "6B", ")", ",", "the", "combination", "of", "Trametinib", "and", "prednisolone", "greatly", "enhanced", "the", "efficacy", "of", "prednisolone", ",", "especially", "at", "higher", "concentrations", "(", "Figure", "6A", ")", "." ],
  "event_indices" : [ 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 23, 24 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 27, 28 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Moreover", ",", "Ari", "e", "s", "et", "al.", "found", "Trametinib", "could", "restore", "prednisolone", "sensitivity", "in", "RAS-mutant", "BCP-ALL", "patient", "samples", ",", "whereas", "Rambal", "et", "al.", "showed", "that", "MEK", "activation", "reduces", "dexamethasone", "sensitivity", ",", "and", "the", "MEK", "inhibitor", "PD183452", "enhanced", "dexamethasone", "responses", "in", "ALL", "cells", "in", "a", "BIM", "dependent", "manner", "[", "24", ",", "25", "]", "." ],
  "event_indices" : [ 35, 36, 37, 38 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 35, 36 ],
  "controlled_indices" : [ 37, 38 ],
  "trigger_indices" : [ 36, 37 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Since", "SEM", "cells", "responded", "modestly", "to", "MEK", "inhibition", "but", "did", "show", "a", "significant", "loss", "of", "p-ERK", "levels", ",", "we", "investigated", "whether", "these", "cells", "could", "circumvent", "loss", "of", "ERK", "activation", "by", "upregulating", "RAS", "mediated", "PI3K-Akt-mTOR", "signaling", "." ],
  "event_indices" : [ 31, 32, 33, 34 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 31, 32 ],
  "controlled_indices" : [ 33, 34 ],
  "trigger_indices" : [ 32, 33 ],
  "rule_name" : "Positive_early_activation",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "MEK", "inhibitors", "MEK162", ",", "Selumetinib", "and", "Trametinib", "significantly", "reduce", "viability", "of", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 3, 4 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "MEK", "inhibitors", "induce", "apoptosis", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1, 2 ],
  "controlled_indices" : [ 3, 4 ],
  "trigger_indices" : [ 2, 3 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "However", ",", "we", "did", "confirm", "that", "MEK", "inhibitors", "reduced", "p-ERK", "levels", ",", "and", "induced", "apoptosis", "in", "the", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 6, 7, 8 ],
  "controlled_indices" : [ 14, 15 ],
  "trigger_indices" : [ 13, 14 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "However", ",", "we", "did", "confirm", "that", "MEK", "inhibitors", "reduced", "p-ERK", "levels", ",", "and", "induced", "apoptosis", "in", "the", "RAS-mutant", "MLL", "rearranged", "ALL", "cells", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 6, 7, 8 ],
  "controlled_indices" : [ 18, 19 ],
  "trigger_indices" : [ 13, 14 ],
  "rule_name" : "Positive_activation_syntax_7_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 33, 34 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 33, 34 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 31, 32 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "further", "supported", "by", "our", "previous", "study", "showing", "that", "in", "MLL", "rearranged", "ALL", ",", "prednisolone", "sensitization", "mediated", "by", "pan-BCL-2", "family", "inhibitors", "was", "largely", "driven", "by", "the", "up-regulation", "of", "pro", "apoptotic", "BID", "and", "BIM", "[", "27", "]", "." ],
  "event_indices" : [ 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 31, 32 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Positive_activation_syntax_2_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Acute", "lymphoblastic", "leukemia", "(", "ALL", ")", "in", "infants", "(", "<", "1", "year", "of", "age", ")", "represents", "an", "aggressive", "malignancy", ",", "associated", "with", "high", "relapse", "rates", "and", "a", "poor", "clinical", "outcome", "[", "1", "]", "." ],
  "entity_one_indices" : [ 4, 5 ],
  "entity_two_indices" : [ 0, 1, 2, 3 ]
}, {
  "sentence_tokens" : [ "Mutations", "in", "NRAS", "were", "found", "in", "11", "%", "and", "KRAS", "mutations", "in", "13", "%", "of", "cases", "[", "3", "]", "." ],
  "entity_one_indices" : [ 9, 10 ],
  "entity_two_indices" : [ 2, 3 ]
}, {
  "sentence_tokens" : [ "Moreover", ",", "we", "showed", "that", "the", "presence", "of", "a", "RAS", "mutation", "in", "MLL", "rearranged", "patients", "represented", "an", "independent", "predictive", "factor", "for", "an", "even", "worse", "clinical", "outcome", "in", "this", "high-risk", "group", "." ],
  "entity_one_indices" : [ 12, 13 ],
  "entity_two_indices" : [ 9, 10 ]
}, {
  "sentence_tokens" : [ "Since", "the", "previously", "identified", "RAS", "aberrations", "are", "all", "activating", "mutations", "(", "at", "residues", "G12", ",", "G13", "or", "Q61", ")", ",", "we", "wondered", "whether", "small", "molecule", "inhibitors", "targeting", "RAS", "pathway", "components", "could", "suppress", "RAS-mutant", "leukemic", "cells", "[", "3", ",", "7", "]", "." ],
  "entity_one_indices" : [ 27, 28 ],
  "entity_two_indices" : [ 4, 5 ]
}, {
  "sentence_tokens" : [ "For", "this", "particular", "patient", ",", "no", "RAS", "mutation", "was", "present", "at", "diagnosis", ",", "but", "a", "RAS", "mutation", "could", "be", "identified", "at", "relapse", "." ],
  "entity_one_indices" : [ 15, 16 ],
  "entity_two_indices" : [ 6, 7 ]
}, {
  "sentence_tokens" : [ "Notably", ",", "a", "subset", "of", "the", "RAS-wildtype", "primary", "t", "(", "4", ";", "11", ")", "infant", "ALL", "samples", "also", "responded", "favorably", "to", "the", "MEK", "inhibitors", "(", "Figure", "2B", ")", "." ],
  "entity_one_indices" : [ 22, 23, 24 ],
  "entity_two_indices" : [ 15, 16 ]
}, {
  "sentence_tokens" : [ "No", "significant", "difference", "in", "RAS", "protein", "levels", "was", "observed", "between", "the", "RAS-mutant", "and", "RAS-wildtype", "t", "(", "4", ";", "11", ")", "infant", "ALL", "samples", "using", "Western", "blot", "analysis", "(", "Figure", "3A", ")", "." ],
  "entity_one_indices" : [ 21, 22 ],
  "entity_two_indices" : [ 4, 5 ]
}, {
  "sentence_tokens" : [ "As", "expected", ",", "the", "RAS-mutant", "t", "(", "4", ";", "11", ")", "infant", "ALL", "samples", "showed", "significant", "(", "p", "=0", ".013", ")", "higher", "levels", "of", "RAS", "activation", "as", "compared", "to", "RAS-wildtype", "samples", "(", "Figure", "3B", ")", "." ],
  "entity_one_indices" : [ 24, 25 ],
  "entity_two_indices" : [ 12, 13 ]
}, {
  "sentence_tokens" : [ "Interestingly", ",", "apart", "from", "FLT3", ",", "expression", "of", "TKRs", "is", "relatively", "low", "in", "the", "different", "patient", "samples", "." ],
  "entity_one_indices" : [ 8, 9 ],
  "entity_two_indices" : [ 4, 5 ]
}, {
  "sentence_tokens" : [ "MEK", "inhibition", "results", "in", "reduced", "ERK", "phosphorylation", "." ],
  "entity_one_indices" : [ 5, 6 ],
  "entity_two_indices" : [ 0, 1 ]
}, {
  "sentence_tokens" : [ "Therefore", ",", "the", "downstream", "phosphorylation", "of", "Akt", "(", "Ser437", ")", "and", "p70S6K", "(", "Thr389", ")", "was", "assessed", "by", "immunoblotting", "." ],
  "entity_one_indices" : [ 11, 12 ],
  "entity_two_indices" : [ 6, 7 ]
}, {
  "sentence_tokens" : [ "Subsequently", ",", "we", "investigated", "the", "phenotypic", "effects", "of", "the", "MEK", "inhibitors", "on", "SEM", "and", "KOPN8", "through", "analysis", "of", "early", "and", "late", "apoptosis", "markers", "(", "Annexin-V", "and", "7-AAD", ",", "respectively", ")", ",", "using", "flow-cytometry", "." ],
  "entity_one_indices" : [ 21, 22 ],
  "entity_two_indices" : [ 9, 10, 11 ]
}, {
  "sentence_tokens" : [ "Additionally", ",", "we", "investigated", "cell", "cycle", "progression", "under", "influence", "of", "MEK", "inhibition", "." ],
  "entity_one_indices" : [ 10, 11 ],
  "entity_two_indices" : [ 4, 5, 6 ]
}, {
  "sentence_tokens" : [ "A", "similar", "sensitizing", "effect", "was", "observed", "when", "exposing", "SEM", "and", "KOPN8", "to", "MEK162", "or", "Selumetinib", "in", "combination", "with", "prednisolone", "(", "Supplementary", "Figure", "7A-7D", "and", "7F-7I", ",", "respectively", ")", "." ],
  "entity_one_indices" : [ 14, 15 ],
  "entity_two_indices" : [ 12, 13 ]
}, {
  "sentence_tokens" : [ "Interestingly", ",", "in", "both", "SEM", "and", "KOPN8", "cells", "we", "observed", "F", "values", "<", "0.5", ",", "indicating", "strong", "synergy", "between", "Trametinib", "and", "prednisolone", "." ],
  "entity_one_indices" : [ 21, 22 ],
  "entity_two_indices" : [ 19, 20 ]
}, {
  "sentence_tokens" : [ "However", ",", "MEK", "inhibitor", "exposure", "did", "not", "alter", "GR", "protein", "levels", "in", "either", "SEM", "or", "KOPN8", "cells", "(", "Supplementary", "Figure", "7K", ")", "." ],
  "entity_one_indices" : [ 8, 9 ],
  "entity_two_indices" : [ 2, 3, 4 ]
}, {
  "sentence_tokens" : [ "While", "in", "our", "previous", "study", ",", "we", "identified", "RAS", "mutations", "and", "found", "no", "BRAF", "aberrations", ",", "mutations", "of", "other", "upstream", "regulators", ",", "i.e.", "tyrosine", "kinase", "receptors", ",", "can", "occur", "in", "other", "malignancies", "[", "3", "]", "." ],
  "entity_one_indices" : [ 13, 14 ],
  "entity_two_indices" : [ 8, 9 ]
}, {
  "sentence_tokens" : [ "These", "findings", "do", "not", "support", "the", "hypothesis", "that", "other", "(", "upstream", ")", "mutations", "are", "driving", "RAS-MEK-ERK", "signaling", ",", "but", "also", "do", "not", "explain", "observed", "extensive", "MEK", "inhibitor", "sensitivity", "of", "all", "(", "subclonal", ")", "RAS-mutant", "and", "specified", "RAS-wildtype", "patient", "samples", "." ],
  "entity_one_indices" : [ 25, 26, 27 ],
  "entity_two_indices" : [ 15, 16 ]
}, {
  "sentence_tokens" : [ "The", "prednisolone", "sensitizing", "effect", "of", "MEK", "inhibitors", "proposes", "a", "possible", "role", "for", "RAS-MEK-ERK", "signaling", "in", "the", "response", "to", "glucocorticoids", "." ],
  "entity_one_indices" : [ 12, 13 ],
  "entity_two_indices" : [ 5, 6, 7 ]
}, {
  "sentence_tokens" : [ "All", "inhibitors", "were", "weighed", ",", "dissolved", "in", "dimethyl", "sulfoxide", "(", "DMSO", ")", "and", "stored", "at", "-20", "degrees", "C", "until", "use", "." ],
  "entity_one_indices" : [ 10, 11 ],
  "entity_two_indices" : [ 7, 8, 9 ]
}, {
  "sentence_tokens" : [ "Membranes", "were", "re-probed", "with", "mouse", "monoclonal", "anti-beta-actin", "antibodies", "(", "Sigma-Aldrich", ",", "St.", "Louis", ",", "MO", ",", "USA", ")", "as", "loading", "control", "." ],
  "entity_one_indices" : [ 14, 15 ],
  "entity_two_indices" : [ 5, 6, 7, 8 ]
}, {
  "sentence_tokens" : [ "Briefly", ",", "1", "x", "10", "cells", "were", "isolated", "and", "lysed", "with", "Mg", "Lysis", "Buffer", "(", "MLB", ")", ",", "and", "stored", "at", "-80", "degrees", "C", "until", "use", "." ],
  "entity_one_indices" : [ 15, 16 ],
  "entity_two_indices" : [ 11, 12 ]
}, {
  "sentence_tokens" : [ "GST", "fused", "RAF-1", "RBD", "bead", "slurry", "was", "added", "to", "the", "lysate", "and", "incubated", "for", "1", "hour", "at", "4", "degrees", "C", "while", "agitating", "." ],
  "entity_one_indices" : [ 2, 3 ],
  "entity_two_indices" : [ 0, 1 ]
}, {
  "sentence_tokens" : [ "Annexin-V/7-AAD", "apoptosis", "and", "cell", "cycle", "assays", "." ],
  "entity_one_indices" : [ 3, 4, 5 ],
  "entity_two_indices" : [ 1, 2 ]
}, {
  "sentence_tokens" : [ "Subsequently", ",", "RNAse", "treatment", "was", "performed", ",", "and", "DNA", "was", "stained", "using", "Propidium", "Iodide", ",", "after", "which", "FACS", "determined", "DNA", "content", "." ],
  "entity_one_indices" : [ 17, 18 ],
  "entity_two_indices" : [ 12, 13, 14 ]
}, {
  "sentence_tokens" : [ "Recently", "published", "gene", "expression", "data", "(", "Affymetrix", "HU133plus2.0", ")", "for", "part", "of", "the", "t", "(", "4", ";", "11", ")", "patient", "samples", "was", "available", "(", "i.e.", "for", "6", "of", "9", "MEK", "inhibitor", "resistant", "RAS-wildtype", "samples", ",", "4", "of", "5", "sensitive", "RAS-wildtype", "samples", "and", "3", "of", "6", "RAS-mutant", "samples", ")", "[", "29", "]", "." ],
  "entity_one_indices" : [ 29, 30, 31 ],
  "entity_two_indices" : [ 2, 3, 4 ]
} ]